Mar 012024
Drug Name |
Active Ingredient(s) |
Approval Date |
FDA-Approved Use on Approval Date |
Press Release |
Drug Trials Snapshot |
| Letybo | letibotulinumtoxinA-wlbg | 2/29/2024 | To temporarily improve the appearance of moderate-to-severe glabellar lines | Drug Trials Snapshot | |
| Exblifep | cefepime, enmetazobactam | 2/22/2024 | To treat complicated urinary tract infections | Drug Trials Snapshot |
Sorry, the comment form is closed at this time.